tiprankstipranks
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF
US Market
IPHYF
Innate Pharma SA
RESEARCH TOOLSreports

Innate Pharma SA (IPHYF) Financial Statements

27 Followers

Innate Pharma SA Financial Overview

Innate Pharma SA's market cap is currently $127.83M. The company's EPS TTM is $-0.36354939999999997; its P/E ratio is -1.31; Innate Pharma SA is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 2.79M€ 12.62M€ 51.90M€ 49.64M€ 12.11M
Gross Profit€ 2.79M€ -31.86M€ 5.62M€ 6.01M€ -34.89M
Operating Income€ -57.36M€ -51.58M€ -12.67M€ -24.63M€ -47.83M
EBITDA€ -58.84M€ -50.99M€ -1.84M€ -61.30M€ -43.23M
Net Income€ -49.18M€ -49.47M€ -7.57M€ -58.10M€ -52.81M
Balance Sheet
Cash & Short-Term Investments€ 34.31M€ 80.77M€ 92.46M€ 101.48M€ 119.84M
Total Assets€ 62.72M€ 111.06M€ 184.19M€ 207.86M€ 267.50M
Total Debt€ 22.57M€ 31.37M€ 39.89M€ 42.25M€ 44.25M
Net Debt€ -5.52M€ -35.03M€ -30.71M€ -41.97M€ -59.51M
Total Liabilities€ 84.42M€ 102.22M€ 132.29M€ 153.71M€ 160.06M
Stockholders' Equity€ -21.70M€ 8.83M€ 51.90M€ 54.15M€ 107.44M
Cash Flow
Free Cash Flow€ -52.90M€ -7.29M€ -34.91M€ -20.28M€ -59.79M
Operating Cash Flow€ -52.76M€ -6.90M€ -32.56M€ -19.15M€ -58.46M
Investing Cash Flow€ 7.29M€ 9.20M€ 20.63M€ 1.88M€ -917.00K
Financing Cash Flow€ 6.07M€ -6.01M€ -1.97M€ -1.83M€ 26.82M
Currency in EUR

Innate Pharma SA Earnings and Revenue History

Income Statement >

Innate Pharma SA Debt to Assets

Balance Sheet >

Innate Pharma SA Cash Flow

Cash Flow >

Innate Pharma SA Forecast EPS vs Actual EPS

Earnings >